MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidateKen‐ichi Yoshida, William J. Watkins, Makoto Takemura et al.|Bioorganic & Medicinal Chemistry|2007Cited by 130
MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimizationKiyoshi Nakayama, William J. Watkins, Yohei Ishida et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 82
Requirement of CDC45 for Postimplantation Mouse DevelopmentKen‐ichi Yoshida, Anindya Dutta, Arlene H. Sharpe et al.|Molecular and Cellular Biology|2001Cited by 39